Balance Sheet HBM Healthcare Investments AG

Equities

HBMN

CH0012627250

Investment Management & Fund Operators

Market Closed - Swiss Exchange Other stock markets 11:30:57 2025-12-05 am EST			5-day change	1st Jan Change
206.00 ^CHF	+0.24%		-0.96%	+17.05%

Nov. 17	DKSH Reportedly to Weigh Bid for Pharma Distributor Swixx Biopharma	CI
Nov. 17	DKSH Emerges as Contender for Swiss Drug Service Company Swixx BioPharma	MT

d37b37bd5ea0c0a56055.U53CnxmfPyJRVPyUTHoeJ79Sa8HBP0QaJ83GjkflG2E.O8qTpm71blEBMNHmeE1QdoYNDKKGTBVQQ_WKwQ2qbDQ06IPGd-5RFxkdlw

Published financial data: HBM HEALTHCARE INVESTMENTS AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Gain (Loss) on Sale of Investment, Total (Rev)	710M	-124M	-214M	-122M	-50.68M
Interest And Invest. Income (Rev)	59M	50M	71.5M	125M	73M
Other Revenues, Total	-	-	-	-	-
Total Revenues	769M	-73.78M	-142M	2.98M	22.32M
Gross Profit	769M	-73.78M	-142M	2.98M	22.32M
Selling General & Admin Expenses, Total	9.3M	750K	705K	1.6M	1.59M
Other Operating Expenses	742K	781K	716K	858K	917K
Other Operating Expenses, Total	10.04M	1.53M	1.42M	2.46M	2.5M
Operating Income	759M	-75.31M	-144M	520K	19.82M
Interest Expense, Total	-2.47M	-2.72M	-2.65M	-1.7M	-1.33M
Interest And Investment Income	-	-	-	94K	49K
Net Interest Expenses	-2.47M	-2.72M	-2.65M	-1.6M	-1.28M
Currency Exchange Gains (Loss)	-	-	-	-	-
EBT, Excl. Unusual Items	756M	-78.03M	-146M	-1.08M	18.54M
EBT, Incl. Unusual Items	756M	-78.03M	-146M	-1.08M	18.54M
Earnings From Continuing Operations	756M	-78.03M	-146M	-1.08M	18.54M
Net Income to Company	756M	-78.03M	-146M	-1.08M	18.54M
Net Income - (IS)	756M	-78.03M	-146M	-1.08M	18.54M
Net Income to Common Incl Extra Items	756M	-78.03M	-146M	-1.08M	18.54M
Net Income to Common Excl. Extra Items	756M	-78.03M	-146M	-1.08M	18.54M
Per Share Items
Net EPS - Basic	108.71	-11.22	-21.03	-0.16	2.72
Basic EPS - Continuing Operations	108.71	-11.22	-21.03	-0.16	2.72
Basic Weighted Average Shares Outstanding	6.96M	6.96M	6.96M	6.93M	6.8M
Net EPS - Diluted	108.71	-11.22	-21.03	-0.16	2.72
Diluted EPS - Continuing Operations	108.71	-11.22	-21.03	-0.16	2.72
Diluted Weighted Average Shares Outstanding	6.96M	6.96M	6.96M	6.93M	6.8M
Normalized Basic EPS	67.94	-7.01	-13.14	-0.1	1.7
Normalized Diluted EPS	67.94	-7.01	-13.14	-0.1	1.7
Dividend Per Share	9.5	9.7	7.5	7.5	7.5
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITA	759M	-75.31M	-144M	520K	19.82M
EBIT	759M	-75.31M	-144M	520K	19.82M
Total Revenues (As Reported)	769M	-73.78M	-142M	2.98M	22.32M
Normalized Net Income	473M	-48.77M	-91.45M	-677K	11.59M
Interest on Long-Term Debt	2.5M	2.6M	2.65M	1.3M	1.3M
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	6.03M	5.39M	5.73M	10.23M	2.48M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	6.03M	5.39M	5.73M	10.23M	2.48M
Accounts Receivable, Total	17K	20K	16K	60K	37K
Total Receivables	17K	20K	16K	60K	37K
Total Current Assets	6.05M	5.41M	5.75M	10.29M	2.52M
Long-term Investments	2.26B	2.13B	1.92B	1.8B	1.75B
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	2.26B	2.14B	1.92B	1.81B	1.75B
Liabilities
Accrued Expenses, Total	8.15M	-	-	-	-
Current Portion of Long-Term Debt	49.97M	-	49.98M	-	-
Other Current Liabilities	2.47M	2.04M	2.17M	3.31M	3.12M
Total Current Liabilities	60.59M	2.04M	52.15M	3.31M	3.12M
Long-Term Debt	49.8M	149M	99.21M	99.39M	99.57M
Total Liabilities	110M	151M	151M	103M	103M
Common Stock, Total	291M	204M	136M	84.22M	32.02M
Retained Earnings	1.72B	1.64B	1.49B	1.49B	1.51B
Treasury Stock	-402K	-402K	-402K	-15.99M	-41.76M
Comprehensive Income and Other	142M	142M	142M	142M	143M
Total Common Equity	2.15B	1.99B	1.77B	1.7B	1.65B
Total Equity	2.15B	1.99B	1.77B	1.7B	1.65B
Total Liabilities And Equity	2.26B	2.14B	1.92B	1.81B	1.75B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	6.96M	6.96M	6.96M	6.87M	6.73M
ECS Total Common Shares Outstanding	6.96M	6.96M	6.96M	6.87M	6.73M
Book Value / Share	309.25	285.53	254.8	248.1	244.41
Tangible Book Value	2.15B	1.99B	1.77B	1.7B	1.65B
Tangible Book Value Per Share	309.25	285.53	254.8	248.1	244.41
Total Debt	99.77M	149M	149M	99.39M	99.57M
Net Debt	93.74M	144M	143M	89.16M	97.09M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	756M	-78.03M	-146M	-1.08M	18.54M
Other Operating Activities, Total	-759M	67.83M	145M	-622K	-20.9M
Cash from Operations	-3.23M	-10.2M	-1.29M	-1.7M	-2.36M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Other Investing Activities, Total	59M	50M	71.5M	125M	73M
Cash from Investing	59M	50M	71.5M	125M	73M
Long-Term Debt Issued, Total	-	98.9M	-	-	-
Total Debt Issued	-	98.9M	-	-	-
Long-Term Debt Repaid, Total	-	-50M	-	-50M	-
Total Debt Repaid	-	-50M	-	-50M	-
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-53.57M	-86.96M	-67.48M	-66.5M	-77.29M
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-2.27M	-2.39M	-2.38M	-2.3M	-1.09M
Cash from Financing	-55.84M	-40.45M	-69.87M	-119M	-78.39M
Foreign Exchange Rate Adjustments	-	-	-	-	-
Net Change in Cash	-63K	-645K	344K	4.5M	-7.75M
Supplemental Items
Cash Interest Paid	2.27M	2.39M	2.38M	2.3M	1.09M
Levered Free Cash Flow	479M	-57.35M	-91.32M	361K	11.38M
Unlevered Free Cash Flow	481M	-55.65M	-89.66M	1.42M	12.21M
Change In Net Working Capital	-6.81M	8.58M	-132K	-1.1M	175K
Net Debt Issued / Repaid	-	48.9M	-	-50M	-

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	24.87	-2.14	-4.42	0.02	0.7
Return on Total Capital	24.96	-2.15	-4.43	0.02	0.7
Return On Equity %	42.01	-3.77	-7.78	-0.06	1.11
Return on Common Equity	42.01	-3.77	-7.78	-0.06	1.11
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	1.21	-1.02	-0.5	53.79	7.1
EBITA Margin %	98.69	102.08	101	17.44	88.79
EBIT Margin %	98.69	102.08	101	17.44	88.79
Income From Continuing Operations Margin %	98.37	105.76	102.86	-36.32	83.07
Net Income Margin %	98.37	105.76	102.86	-36.32	83.07
Net Avail. For Common Margin %	98.37	105.76	102.86	-36.32	83.07
Normalized Net Income Margin	61.48	66.1	64.29	-22.7	51.92
Levered Free Cash Flow Margin	62.37	77.73	64.2	12.12	51
Unlevered Free Cash Flow Margin	62.57	75.43	63.03	47.69	54.71
Asset Turnover
Asset Turnover	0.4	-0.03	-0.07	0	0.01
Short Term Liquidity
Current Ratio	0.1	2.64	0.11	3.1	0.81
Quick Ratio	0.1	2.64	0.11	3.1	0.81
Operating Cash Flow to Current Liabilities	-0.05	-4.99	-0.02	-0.51	-0.76
Long Term Solvency
Total Debt/Equity	4.64	7.5	8.42	5.83	6.05
Total Debt / Total Capital	4.43	6.97	7.76	5.51	5.71
LT Debt/Equity	2.31	7.5	5.6	5.83	6.05
Long-Term Debt / Total Capital	2.21	6.97	5.16	5.51	5.71
Total Liabilities / Total Assets	4.88	7.06	7.87	5.68	5.87
EBIT / Interest Expense	306.93	-27.72	-54.24	0.31	14.95
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	307.57	-109.6	92.79	-102.1	648.56
Gross Profit, 1 Yr. Growth %	307.57	-109.6	92.79	-102.1	648.56
EBITA, 1 Yr. Growth %	309.84	-109.93	90.76	-100.36	3.71K
EBIT, 1 Yr. Growth %	309.84	-109.93	90.76	-100.36	3.71K
Earnings From Cont. Operations, 1 Yr. Growth %	313.95	-110.32	87.51	-99.26	-1.81K
Net Income, 1 Yr. Growth %	313.95	-110.32	87.51	-99.26	-1.81K
Normalized Net Income, 1 Yr. Growth %	313.95	-110.32	87.51	-99.26	-1.81K
Diluted EPS Before Extra, 1 Yr. Growth %	313.95	-110.32	87.51	-99.26	-1.84K
Accounts Receivable, 1 Yr. Growth %	-37.04	17.65	-20	275	-38.33
Total Assets, 1 Yr. Growth %	45.72	-5.5	-9.98	-6.11	-3.24
Tangible Book Value, 1 Yr. Growth %	48.5	-7.67	-10.76	-3.88	-3.43
Common Equity, 1 Yr. Growth %	48.5	-7.67	-10.76	-3.88	-3.43
Cash From Operations, 1 Yr. Growth %	-22.41	216.09	-87.37	32.38	38.48
Levered Free Cash Flow, 1 Yr. Growth %	322.38	-111.96	59.22	-100.4	3.05K
Unlevered Free Cash Flow, 1 Yr. Growth %	318.14	-111.57	61.1	-101.59	758.78
Dividend Per Share, 1 Yr. Growth %	23.38	2.11	-22.68	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	88.87	-37.46	-56.98	-79.9	-60.39
Gross Profit, 2 Yr. CAGR %	88.87	-37.46	-56.98	-79.9	-60.39
EBITA, 2 Yr. CAGR %	89.4	-36.22	-56.49	-91.69	-62.86
EBIT, 2 Yr. CAGR %	89.4	-36.22	-56.49	-91.69	-62.86
Earnings From Cont. Operations, 2 Yr. CAGR %	90.19	-34.65	-56.01	-88.22	-64.4
Net Income, 2 Yr. CAGR %	90.19	-34.65	-56.01	-88.22	-64.4
Normalized Net Income, 2 Yr. CAGR %	90.19	-34.65	-56.01	-88.22	-64.4
Diluted EPS Before Extra, 2 Yr. CAGR %	90.19	-34.65	-56.01	-88.2	-64.01
Accounts Receivable, 2 Yr. CAGR %	-19.14	-13.93	-2.99	73.21	52.07
Total Assets, 2 Yr. CAGR %	26.11	17.35	-7.77	-8.07	-4.68
Tangible Book Value, 2 Yr. CAGR %	27.75	17.1	-9.23	-7.39	-3.66
Common Equity, 2 Yr. CAGR %	27.75	17.1	-9.23	-7.39	-3.66
Cash From Operations, 2 Yr. CAGR %	6.35	56.6	-36.81	-59.11	35.39
Levered Free Cash Flow, 2 Yr. CAGR %	90.72	-28.92	-56.36	-92.06	-64.69
Unlevered Free Cash Flow, 2 Yr. CAGR %	89.94	-30.45	-56.83	-84.02	-63.09
Dividend Per Share, 2 Yr. CAGR %	12.55	12.24	-11.15	-12.07	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	85.17	-30.04	-8.98	-84.29	-32.87
Gross Profit, 3 Yr. CAGR %	85.17	-30.04	-8.98	-84.29	-32.87
EBITA, 3 Yr. CAGR %	85.79	-29.12	-8.1	-91.18	-35.92
EBIT, 3 Yr. CAGR %	85.79	-29.12	-8.1	-91.18	-35.92
Earnings From Cont. Operations, 3 Yr. CAGR %	86.88	-28	-7.13	-88.73	-38.06
Net Income, 3 Yr. CAGR %	86.88	-28	-7.13	-88.73	-38.06
Normalized Net Income, 3 Yr. CAGR %	86.88	-28	-7.13	-88.73	-38.06
Diluted EPS Before Extra, 3 Yr. CAGR %	87.27	-28	-7.13	-88.72	-37.6
Accounts Receivable, 3 Yr. CAGR %	-22.84	-8.37	-16.01	52.25	22.76
Total Assets, 3 Yr. CAGR %	21.52	14.55	7.42	-7.22	-6.48
Tangible Book Value, 3 Yr. CAGR %	22.94	14.65	6.96	-7.48	-6.09
Common Equity, 3 Yr. CAGR %	22.94	14.65	6.96	-7.48	-6.09
Cash From Operations, 3 Yr. CAGR %	0.81	52.91	-32.34	-19.15	-38.59
Levered Free Cash Flow, 3 Yr. CAGR %	88.47	-24.22	-7	-90.9	-41.67
Unlevered Free Cash Flow, 3 Yr. CAGR %	87.36	-25.27	-7.97	-85.65	-39.68
Dividend Per Share, 3 Yr. CAGR %	10.72	8.95	-0.87	-7.58	-8.22
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	95.07	-12.32	3.27	-57.52	-34.74
Gross Profit, 5 Yr. CAGR %	95.07	-12.32	3.27	-57.52	-34.74
EBITA, 5 Yr. CAGR %	97.03	-11.56	3.96	-69.93	-36.04
EBIT, 5 Yr. CAGR %	97.03	-11.56	3.96	-69.93	-36.04
Earnings From Cont. Operations, 5 Yr. CAGR %	99.71	-10.62	4.78	-65.1	-36.72
Net Income, 5 Yr. CAGR %	99.71	-10.62	4.78	-65.1	-36.72
Normalized Net Income, 5 Yr. CAGR %	99.71	-10.62	4.78	-65.1	-36.72
Diluted EPS Before Extra, 5 Yr. CAGR %	103.55	-9.97	4.91	-65.07	-36.44
Accounts Receivable, 5 Yr. CAGR %	-20.64	-17.07	-15.44	18.2	6.5
Total Assets, 5 Yr. CAGR %	14.75	12.26	8.83	4.9	2.41
Tangible Book Value, 5 Yr. CAGR %	15.76	12.64	8.89	5.27	2.58
Common Equity, 5 Yr. CAGR %	15.76	12.64	8.89	5.27	2.58
Cash From Operations, 5 Yr. CAGR %	-7.56	42.85	-16.37	-9.78	-10.7
Levered Free Cash Flow, 5 Yr. CAGR %	37.2	-7.85	4.98	-69.27	-36.87
Unlevered Free Cash Flow, 5 Yr. CAGR %	37.59	-8.72	4.16	-59.67	-36.15
Dividend Per Share, 5 Yr. CAGR %	11.55	10.83	1.39	0	-0.52